Edwards Lifesciences exec reports small tax share disposition
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Edwards Lifesciences Corp executive Daniel J. Lippis reported a small, routine share disposition tied to tax withholding. On the vesting of equity awards, the issuer withheld 377 shares of common stock at $95.18 per share to cover tax obligations under Rule 16b-3(e).
After this tax-withholding event, Lippis directly holds about 40,033.9103 shares of Edwards Lifesciences common stock. The transaction reflects compensation-related tax settlement rather than an open-market sale or a change in his investment stance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 377 | $95.18 | $36K |
Footnotes (1)
- F1. Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
Key Figures
Key Terms
Rule 16b-3(e) regulatory
tax withholding obligations financial
vesting of securities financial
tax-withholding disposition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Edwards Lifesciences (EW) report for Daniel J. Lippis?
Was Daniel J. Lippis’s Edwards Lifesciences (EW) transaction an open-market sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.